GlaxoSmithKline Beteiligungs GmbH
GlaxoSmithKline Beteiligungs GmbH is a Private limited company (Ltd.) registered in Germany under HRB 139982 München, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is München, Germany. 5 shareholders are on record for GlaxoSmithKline Beteiligungs GmbH, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 16 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for GlaxoSmithKline Beteiligungs GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is Setfirst Limited, holding 58.9% — a majority holding — followed by Setfirst Limited at 22.9%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 6 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Setfirst Limited | 58.9% | Handelsregister (Commercial Register) | |
| Setfirst Limited | 22.9% | Handelsregister (Commercial Register) | |
| Setfirst Limited | 8.2% | Handelsregister (Commercial Register) | |
| GlaxoSmithKline Holdings (One) Limited | 6.6% | Handelsregister (Commercial Register) | |
| GlaxoSmithKline Holdings (One) Limited | 2.6% | Handelsregister (Commercial Register) |
Officers
5
Four of the 5 officer records shown for GlaxoSmithKline Beteiligungs GmbH are current appointments, filed with Handelsregister (Commercial Register). Rene Jensen serves as Geschäftsführer (managing director); Ina Heitmeier (appointed 2008-06-18), Daniel Karl Grießer and Antonina Zanova all serve as Officer. The remaining 1 record shown (Jean-Bernard Siméon) is a former appointment that has since been resigned.
The register reports 15 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at GlaxoSmithKline Beteiligungs GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
GlaxoSmithKline Beteiligungs GmbH sits 4 levels below its ultimate parent, GSK PLC, registered in United Kingdom. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Immediately above GlaxoSmithKline Beteiligungs GmbH is SETFIRST LIMITED, holding 90% as filed in GlaxoSmithKline Beteiligungs GmbH's own shareholder record with Handelsregister (Commercial Register). GSK PLC sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans Germany jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
GSK PLC
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns GlaxoSmithKline Beteiligungs GmbH?
Five shareholders are currently on record for GlaxoSmithKline Beteiligungs GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is Setfirst Limited, holding 58.9% — a majority holding — followed by Setfirst Limited at 22.9%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is GlaxoSmithKline Beteiligungs GmbH's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for GlaxoSmithKline Beteiligungs GmbH is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does GlaxoSmithKline Beteiligungs GmbH have on record?
5 shareholders are shown on record for GlaxoSmithKline Beteiligungs GmbH. The register reports 6 in total; only the top 5 by holding are shown here.
What is GlaxoSmithKline Beteiligungs GmbH's company registration number?
GlaxoSmithKline Beteiligungs GmbH's registration number is HRB 139982 München, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is GlaxoSmithKline Beteiligungs GmbH still an active company?
GlaxoSmithKline Beteiligungs GmbH's status on Handelsregister (Commercial Register) is listed as active.
What is GlaxoSmithKline Beteiligungs GmbH's registered address?
The registered address on file for GlaxoSmithKline Beteiligungs GmbH is München, Germany.
Who are the officers/directors of GlaxoSmithKline Beteiligungs GmbH?
Four of the 5 officer records shown for GlaxoSmithKline Beteiligungs GmbH are current appointments, filed with Handelsregister (Commercial Register). Rene Jensen serves as Geschäftsführer (managing director); Ina Heitmeier (appointed 2008-06-18), Daniel Karl Grießer and Antonina Zanova all serve as Officer. The remaining 1 record shown (Jean-Bernard Siméon) is a former appointment that has since been resigned. Management authority at GlaxoSmithKline Beteiligungs GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does GlaxoSmithKline Beteiligungs GmbH have a parent company or subsidiaries?
GlaxoSmithKline Beteiligungs GmbH sits 4 levels below its ultimate parent, GSK PLC, registered in United Kingdom. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Those 1 subsidiary spans Germany jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to GlaxoSmithKline Beteiligungs GmbH's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to GlaxoSmithKline Beteiligungs GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access GlaxoSmithKline Beteiligungs GmbH's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like GlaxoSmithKline Beteiligungs GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 16 October 2026.